PharmAthene to Present at the Noble Financial Sixth Annual Equity Conference on Monday, June 7, 2010

Jun 01, 2010, 11:39 ET from PharmAthene, Inc.

ANNAPOLIS, Md., June 1 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP) a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Company will present at the Noble Financial Sixth Annual Equity Conference 'ONTRACK 2010' on Monday, June 7, 2010 at 4:00 p.m. ET in Room 3 - Piquet.  The Company's presentation will be available via webcast under the Investor Relations section at the Company's website at: www.PharmAthene.com.

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

  • SparVax™ - a second generation recombinant protective antigen (rPA) anthrax vaccine
  • Third generation rPA anthrax vaccine
  • Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection
  • Protexia® - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents

For more information about PharmAthene, please visit www.PharmAthene.com.

SOURCE PharmAthene, Inc.



RELATED LINKS

http://www.PharmAthene.com